American Heart Journal
Volume 147, Issue 5 , Pages 924-930, May 2004

Are hematinic deficiencies the cause of anemia in chronic heart failure?

  • Klaus K.A Witte, MRCP

      Affiliations

    • Division of Academic Cardiology, Castle Hill Hospital, Cottingham, United Kingdom
    • Corresponding Author InformationReprint requests: K Witte, MRCP, Academic Cardiology, Castle Hill Hospital, Castle Road, Cottingham, Hull HU16 5JQ UK.
  • ,
  • Ramesh Desilva, MRCP

      Affiliations

    • Division of Academic Cardiology, Castle Hill Hospital, Cottingham, United Kingdom
  • ,
  • Sudipta Chattopadhyay, MRCP

      Affiliations

    • Division of Academic Cardiology, Castle Hill Hospital, Cottingham, United Kingdom
  • ,
  • Justin Ghosh, MRCP

      Affiliations

    • Division of Academic Cardiology, Castle Hill Hospital, Cottingham, United Kingdom
  • ,
  • John G.F Cleland, MD

      Affiliations

    • Division of Academic Cardiology, Castle Hill Hospital, Cottingham, United Kingdom
  • ,
  • Andrew L Clark, MD

      Affiliations

    • Division of Academic Cardiology, Castle Hill Hospital, Cottingham, United Kingdom

Received 19 June 2003; accepted 11 November 2003.

Abstract 

Background

Anemia in chronic heart failure (CHF) is common, varying in prevalence between 14.4% and 55%, and is more frequent in patients with more severe heart failure. Patients with CHF who have anemia have a poorer quality of life, higher hospital admission rates, and reduced exercise tolerance. We explored the relation between hematinic levels and hemoglobin (Hb) levels and exercise tolerance in a group of patients with CHF.

Methods

We analyzed data from 173 patients with left ventricular systolic dysfunction (LVSD), 123 patients with symptoms of heart failure, but preserved left ventricular (LV) systolic function (“diastolic dysfunction”), and 58 control subjects of similar age. Each underwent echocardiography, a 6-minute walk test, and blood tests for renal function and Hb and hematinic levels (vitamin B12, iron, and folate). We classified patients as having no anemia (Hb level >12.5 g/dL), mild anemia (Hb level from 11.5–12.5 g/dL), or moderate anemia (Hb level <11.5 g/dL).

Results

Of patients with LVSD, 16% had moderate anemia and 19% had mild anemia. Of patients with preserved LV function, 16% had moderate anemia and 17% had mild anemia. Four control subjects had a Hb level <12.5 g/dL. Of all patients, 6% were vitamin B12 deficient, 13% were iron deficient, and 8% were folate deficient. There was no difference between patients with LVSD and the diastolic dysfunction group. In patients with LVSDS, the average Hb level was lower in New York Heart Association class III than classes II and I. The distance walked in 6 minutes correlated with Hb level in both groups of patients with CHF (r = 0.29; P <.0001). Patients with anemia achieved a lower pVo2 (15.0 [2.3] vs 19.5 [4.4], P < .05). Peak oxygen consumption correlated with Hb level (r = 0.21, P <.05) in the patients, but not in the control subjects. In patients with anemia, the mean creatinine level was higher than in patients with a Hb level >12.5 g/dL, but there was no clear relationship with simple regression. Hematocrit level and mean corpuscular volume were not different in the patients with diastolic dysfunction, patients with LV dysfunction, or the control subjects. Hematocrit levels were not influenced by diuretic dose. Patients with anemia were not more likely to be hematinic deficient than patients without anemia.

Conclusions

Patients with symptoms and signs of CHF have a high prevalence of anemia (34%) whether they have LV dysfunction or diastolic dysfunction, but few patients have hematinic deficiency. Hemoglobin levels correlate with subjective and objective measures of severity and renal function.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-8703(03)00795-6

doi:10.1016/j.ahj.2003.11.007

American Heart Journal
Volume 147, Issue 5 , Pages 924-930, May 2004